Agios Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar todayAgios Pharmaceuticals, Inc. net revenue for today is 0 $. The dynamics of Agios Pharmaceuticals, Inc. net revenue fell by -44 045 000 $ compared to the previous report. Net income Agios Pharmaceuticals, Inc. - 1 874 325 000 $. Information about net income is used from open sources. Graph of finance company Agios Pharmaceuticals, Inc.. The financial graph of Agios Pharmaceuticals, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. The value of "net income" Agios Pharmaceuticals, Inc. on the graph is displayed in blue. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Agios Pharmaceuticals, Inc. quarterly report datesCost of revenue Agios Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Agios Pharmaceuticals, Inc. is 57 667 000 $ Operating income Agios Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Agios Pharmaceuticals, Inc. is -91 217 000 $ Net income Agios Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Agios Pharmaceuticals, Inc. is 1 874 325 000 $ |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Current assets Agios Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Agios Pharmaceuticals, Inc. is 2 355 114 000 $ Total assets Agios Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Agios Pharmaceuticals, Inc. is 2 488 434 000 $ Current cash Agios Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Agios Pharmaceuticals, Inc. is 1 888 025 000 $
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Last revenue report of Agios Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Agios Pharmaceuticals, Inc. was 0 US dollar and changed by -100% since last year. Net income in Agios Pharmaceuticals, Inc. was 1 874 325 000 $ in last quartal, net income changes to 0%. |